首頁 › 轉移性癌症 › 維吉尼亞州 › Arlington
Arlington, VA 的 轉移性癌症 臨床試驗
53 項針對 轉移性癌症 的研究正在 Arlington（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
招募中3 期
- Virginia Cancer Specialists, Fairfax · 距離 11 英里
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
招募中2 期
- Inova Fairfax Hospital, Falls Church · 距離 4 英里
- Inova Schar Cancer Institute, Fairfax · 距離 11 英里
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
招募中1 期
- Inova Schar Cancer Institute, Fairfax · 距離 11 英里
- NEXT Virginia, Fairfax · 距離 11 英里
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
招募中1/2 期
- Virginia Cancer Specialists, Fairfax · 距離 11 英里
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
招募中1 期
- Virginia Cancer Specialists, Fairfax · 距離 11 英里
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
招募中1 期
- NEXT Virginia, Fairfax · 距離 11 英里
A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours
招募中1/2 期
- NEXT Oncology, Fairfax · 距離 11 英里
A Study of ASP3082 in Adults With Advanced Solid Tumors
招募中1 期
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 距離 11 英里
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
招募中1 期
- ALX Center 2, Fairfax · 距離 11 英里
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
招募中2/3 期
- Virginia Cancer Specialists - Fairfax Office, Fairfax · 距離 11 英里
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
招募中3 期
- Virginia Cancer Specialists, PC, Arlington
- Virginia Cancer Specialists, PC, Fairfax · 距離 11 英里
- Virginia Cancer Specialists, PC, Reston · 距離 14 英里
- 還有 1 項
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
招募中1 期
- NEXT Oncology Virginia, Fairfax · 距離 11 英里
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
招募中3 期
- Research Site, Fairfax · 距離 11 英里
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
招募中2 期
- Virginia Cancer Specialists, Fairfax · 距離 11 英里
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
招募中1 期
- NEXT Oncology, Fairfax · 距離 11 英里
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
招募中1/2 期
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 距離 11 英里
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
招募中3 期
- Virginia Cancer Specialists, Fairfax · 距離 11 英里
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
招募中1/2 期
- NEXT Oncology Virginia, Fairfax · 距離 11 英里
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
招募中1/2 期
- Next Oncology Virginia Cancer Specialist, Fairfax · 距離 11 英里
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
招募中1/2 期
- Virginia Cancer Specialists, PC, Fairfax · 距離 11 英里
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
招募中1 期
- NEXT Oncology, Fairfax · 距離 11 英里
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
招募中1 期
- USO-Virginia Cancer Specialists, PC, Fairfax · 距離 11 英里
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
招募中3 期
- USO - Virginia Cancer Specialists, Fairfax · 距離 11 英里
NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor Malignancies
招募中1 期
- NEXT, Fairfax · 距離 11 英里
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
招募中1/2 期
- Avenzo Therapeutics Recruiting Site, Fairfax · 距離 11 英里
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
招募中1 期
- Virginia Cancer Specialists, Fairfax · 距離 11 英里
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
招募中1 期
- NEXT Virginia, Fairfax · 距離 11 英里
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
招募中1 期
- NEXT Virginia, Fairfax · 距離 11 英里
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
招募中2 期
- Inova Schar Cancer Institute, Fairfax · 距離 11 英里
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
招募中1/2 期
- Crinetics Study Site, Fairfax · 距離 11 英里
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
招募中1/2 期
- Virginia Cancer Specialists, Fairfax · 距離 11 英里
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
招募中3 期
- Research Site, Falls Church · 距離 4 英里
- Research Site, Fairfax · 距離 11 英里
A Study of ASP1002 in Adults for Treatment of Solid Tumors
招募中1 期
- NEXT Oncology Virginia, Fairfax · 距離 11 英里
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
招募中1 期
- Virginia Cancer Specialists, Fairfax · 距離 11 英里
A Study of PYX-201 in Advanced Solid Tumors
招募中1 期
- NEXT Virginia, Fairfax · 距離 11 英里
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
招募中1 期
- NEXT Virginia, Fairfax · 距離 11 英里
A Study of LY4175408 in Participants With Advanced Cancer
招募中1 期
- NEXT Virginia, Fairfax · 距離 11 英里
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
招募中1 期
- Research Site, Fairfax · 距離 11 英里
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
招募中1 期
- Research Site, Fairfax · 距離 11 英里
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
招募中1 期
- NEXT Oncology Virginia, Fairfax · 距離 11 英里
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
招募中1/2 期
- NEXT Oncology, Fairfax · 距離 11 英里
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
招募中1 期
- NEXT Oncology Virginia, Fairfax · 距離 11 英里
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
招募中1/2 期
- Next Oncology Virginia, Fairfax · 距離 11 英里
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
招募中1/2 期
- Virginia Cancer Specialists, Fairfax · 距離 11 英里
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
招募中2/3 期
- Inova Schar Cancer, Fairfax · 距離 11 英里
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
招募中1 期
- NEXT Virginia, Fairfax · 距離 11 英里
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
招募中1/2 期
- Virginia Cancer Specialists, Fairfax · 距離 11 英里
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
招募中1 期
- NEXT Virginia, Fairfax · 距離 11 英里
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
招募中1/2 期
- NEXT Virginia, Fairfax · 距離 11 英里
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
招募中1 期
- NEXT Virigina, Fairfax · 距離 11 英里
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
招募中1 期
- Virginia Cancer Specialists, Fairfax · 距離 11 英里
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
招募中1 期
- Virginia Cancer Specialists, Fairfax · 距離 11 英里
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
招募中1/2 期
- NEXT Virginia, Fairfax · 距離 11 英里
其他城市的 轉移性癌症 試驗
- Houston, TX104 項研究
- New York City, NY93 項研究
- Nashville, TN70 項研究
- Boston, MA63 項研究
- Los Angeles, CA57 項研究
- St. Louis, MO54 項研究
- Philadelphia, PA46 項研究
- Chicago, IL45 項研究
- San Antonio, TX44 項研究
- Washington, DC43 項研究
- Dallas, TX42 項研究
- Seattle, WA39 項研究
Arlington 的其他研究
- 非小細胞肺癌104 項研究
- 大腸直腸癌52 項研究
- 癌症（所有類型）48 項研究
- 乳癌47 項研究
- 卵巢癌46 項研究
- 肺癌41 項研究
- 子宮內膜癌39 項研究
- 胰臟癌33 項研究
- 頭頸部鱗狀細胞癌26 項研究
- 小細胞肺癌23 項研究
- 胃癌20 項研究
- 三陰性乳癌20 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。